Ghostwriting - Guest Authorship and Ghostwriting in Publications Related to Rofecoxib A Case Study of Industry Documents From Rofecoxib Litigation

Info iconThis preview shows pages 1–3. Sign up to view the full content.

View Full Document Right Arrow Icon
current as of September 16, 2010. Online article and related content http://jama.ama-assn.org/cgi/content/full/299/15/1800 . 2008;299(15):1800-1812 (doi:10.1001/jama.299.15.1800) JAMA Joseph S. Ross; Kevin P. Hill; David S. Egilman; et al. Documents From Rofecoxib Litigation Related to Rofecoxib: A Case Study of Industry Guest Authorship and Ghostwriting in Publications Correction Contact me if this article is corrected. Citations Contact me when this article is cited. This article has been cited 90 times. Topic collections Contact me when new articles are published in these topic areas. Drug Therapy, Other; Humanities; Medicine and the Media Neurology; Alzheimer Disease; Statistics and Research Methods; Drug Therapy; Journalology/ Peer Review/ Authorship; Medical Practice; Medical Ethics; the same issue Related Articles published in . 2008;299(15):1833. JAMA Catherine D. DeAngelis et al. Influence Impugning the Integrity of Medical Science: The Adverse Effects of Industry . 2008;299(15):1813. JAMA Bruce M. Psaty et al. Litigation Cognitive Impairment: A Case Study Based on Documents From Rofecoxib Reporting Mortality Findings in Trials of Rofecoxib for Alzheimer Disease or Related Letters . 2008;300(8):905. JAMA Catherine D. DeAngelis et al. In Reply: . 2008;300(8):902. JAMA Serban-Dan Costa. . 2008;300(8):902. JAMA Richard Balon. . 2008;300(8):901. JAMA Steven Ferris et al. . 2008;300(8):901. JAMA Christopher J. Hawkey. . 2008;300(8):901. JAMA Carlo Patrono. . 2008;300(8):900. JAMA Garret A. FitzGerald. Guest Authorship, Mortality Reporting, and Integrity in Rofecoxib Studies http://pubs.ama-assn.org/misc/permissions.dtl [email protected] Permissions http://jama.com/subscribe Subscribe [email protected] Reprints/E-prints http://jamaarchives.com/alerts Email Alerts at University of Toronto on September 16, 2010 www.jama.com Downloaded from
Background image of page 1

Info iconThis preview has intentionally blurred sections. Sign up to view the full version.

View Full DocumentRight Arrow Icon
SPECIAL COMMUNICATION Guest Authorship and Ghostwriting in Publications Related to Rofecoxib A Case Study of Industry Documents From Rofecoxib Litigation Joseph S. Ross, MD, MHS Kevin P. Hill, MD, MHS David S. Egilman, MD, MPH Harlan M. Krumholz, MD, SM A UTHORSHIP IN BIOMEDICAL publication provides recog- nition while establishing ac- countability and responsibil- ity. Guest authorship has been defined as the designation of an individual who does not meet authorship criteria as an author. 1,2 It was identified in 16% of re- search articles, 26% of review articles, and 21% of editorials in a survey of 6 peer-reviewed medical journals, 3 in ad- dition to 41% of Cochrane reviews. 4 Ghostwriting has been defined as the failure to designate an individual (as an author) who has made a substantial contribution to the research or writ- ing of a manuscript. 1
Background image of page 2
Image of page 3
This is the end of the preview. Sign up to access the rest of the document.

This note was uploaded on 12/03/2010 for the course PHAMACOLOG pcl470 taught by Professor Arnot during the Fall '10 term at University of Toronto- Toronto.

Page1 / 14

Ghostwriting - Guest Authorship and Ghostwriting in Publications Related to Rofecoxib A Case Study of Industry Documents From Rofecoxib Litigation

This preview shows document pages 1 - 3. Sign up to view the full document.

View Full Document Right Arrow Icon
Ask a homework question - tutors are online